D J Mew
Overview
Explore the profile of D J Mew including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
362
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pass H, Mew D, Carbone M, Donington J, Baserga R, Steinberg S
Dev Biol Stand
. 1998 Oct;
94:321-8.
PMID: 9776253
We have evaluated the effect of antisense IGF receptor transcripts on the proliferation and tumorigenicity in an SV40-induced, immunocompetent hamster mesothelioma model (H9A). Expression of IGF-1 and IGF-1 receptor (IGF-1...
2.
Carbone M, Rizzo P, Grimley P, Procopio A, Mew D, Shridhar V, et al.
Nat Med
. 1997 Aug;
3(8):908-12.
PMID: 9256284
We found that simian virus 40 (SV40) induces mesotheliomas in hamsters and that 60% of human mesotheliomas contain and express SV40 sequences, results now confirmed by others [ref. 3-5, and...
3.
Pompetti F, Rizzo P, Simon R, Freidlin B, Mew D, Pass H, et al.
J Cell Biochem
. 1996 Oct;
63(1):37-50.
PMID: 8891902
We investigated the structure and the expression of various oncogenes in three of the most common human bone tumors-osteosarcoma (36 samples from 34 patients), giant cell tumor (10 patients), and...
4.
Pass H, Mew D, Carbone M, Matthews W, Donington J, Baserga R, et al.
Cancer Res
. 1996 Sep;
56(17):4044-8.
PMID: 8752177
We evaluated the effect of antisense insulin-like growth factor (IGF) receptor transcripts on the proliferation and tumorigenicity in an SV40-induced, immunocompetent hamster mesothelioma model (H9A). Expression of IGF-1 and IGF-1...
5.
Pass H, Mew D, Kranda K, Temeck B, Donington J, Rosenberg S
Ann Thorac Surg
. 1996 Jun;
61(6):1609-17.
PMID: 8651757
Background: A phase I trial was initiated to define the feasibility and safety of single-lung isolation perfusion with tumor necrosis factor-alpha, interferon-gamma, and moderate hyperthermia for patients with unresectable pulmonary...
6.
Pass H, Mew D
J Cell Biochem Suppl
. 1996 Jan;
24:142-51.
PMID: 8806096
Pleural mesothelioma is an asbestos-related malignancy characterized by progressive local growth, late metastases, and median survivals between 8 and 18 months. It is only recently that the in vitro and...
7.
Donington J, Mew D, Pass H
Surg Oncol
. 1995 Aug;
4(4):175-85.
PMID: 8528480
Malignant pleural mesothelioma (MPM) is an asbestos-related disease which, although rare, is having a major social impact, and is, for the majority of cases, an incurable illness. There has been...
8.
Pass H, Stevens E, Oie H, Tsokos M, Abati A, Fetsch P, et al.
Ann Thorac Surg
. 1995 Apr;
59(4):835-44.
PMID: 7695406
This report characterizes nine new cell lines derived from patients with malignant pleural mesothelioma. The lines were initiated between July 1990 and July 1992 from solid tumors (5 lines) or...
9.
Sekido Y, Pass H, Bader S, Mew D, Christman M, Gazdar A, et al.
Cancer Res
. 1995 Mar;
55(6):1227-31.
PMID: 7882313
We have found 16 of 28 small cell lung cancers, 17 of 31 non-small cell lung cancers, 2 of 3 carcinoids, and 12 of 14 mesotheliomas that had chromosome 22...
10.
Carbone M, Pass H, Rizzo P, Marinetti M, Di Muzio M, Mew D, et al.
Oncogene
. 1994 Jun;
9(6):1781-90.
PMID: 8183577
Mesotheliomas are pleural, pericardial, or peritoneal neoplasms frequently associated with asbestos exposure, and it is estimated that over the next twenty years up to 80,000 new cases are expected in...